Elsevier

Journal of Hepatology

Volume 25, Issue 4, October 1996, Pages 427-432
Journal of Hepatology

Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia

https://doi.org/10.1016/S0168-8278(96)80200-5Get rights and content

Abstract

Background/Aims: Recent reports have shown a high frequency of anti-hepatitis C virus antibodies in patients with cryoglobulinemia. The factors involved in the production of cryoglobulins in hepatitis C virus-infected patients are unknown. To assess the role of hepatitis C virus genotypes in the pathogenesis of mixed cryoglobulinemia, we analyzed their prevalence in a group of 118 hepatitis C virus-infected patients according to the presence or absence of cryoglobulins.

Methods: The hepatitis C virus genome was typed using the Line Probe Assay (LiPA, Innogenetics), for the most common genotypes (1a, 1b, 2a, 2b, 3, 4 or 5).

Results: Cryoglobulinemia was diagnosed in 60 (51%) patients, 33 (55%) of whom had type II and 27 (45%) type III cryoglobulins. Forty-four (37%) patients had no cryoglobulinemia and 14 (12%) patients had transient cryoglobulins. Cryoglobulins were significantly less prevalent in patients infected by genotype 1a. We found no statistical link between the hepatitis C virus genotype and the presence of symptomatic cryoglobulinemia, or the hepatitis C virus genotype and the type (II or III) of cryoglobulin. Interestingly, all six patients infected by hepatitis C virus genotype 4 or 5 had cryoglobulins.

Conclusions: In patients with hepatitis C virus infection, cryoglobulinemia is not strongly associated with a particular HCV genotype or subtype. The mechanism by which cryoglobulins are produced remains to be elucidated.

References (23)

  • G Diodati et al.

    Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C; evaluation of HCV genotypes during and after long-term follow-up

    Dig Dis Sci

    (1994)
  • Cited by (77)

    • Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

      2018, Journal of Clinical and Experimental Hepatology
      Citation Excerpt :

      HCV appears to have an important etiologic role in MC, since HCV infection (serum anti-HCV antibody or HCV-RNA) can be found in 76–95% of patients with MC.33–35 On the other hand, serum cryoglobulins can be identified in 19–54% of patients with chronic HCV infection, depending on the geographical area, population selection, diagnostic method of MC, and lead-time biases.36–38 However, serum cryoglobulins are generally asymptomatic and present at low levels.

    • Vasculitis related to viral and other microbial agents

      2015, Best Practice and Research: Clinical Rheumatology
      Citation Excerpt :

      Mutations in the N-terminal hypervariable regions 1 and 2 (HVR1 and HVR2) of the E2 envelope glycoprotein were initially thought to predispose to MC via CD81-activated proliferation of peripheral B cells [48,49]. However, viral genotyping studies have overall failed to demonstrate correlations between viral sequences and development of MC or progression of MC to symptomatic disease [50–52]. MCs are produced by marginal zone B cells of lymphoid aggregates in hepatic portal tracts primarily, but bone marrow, lymph nodes, and peripheral mononuclear cells where HCV RNA has been demonstrated may be other sources [53,54].

    • Leukocytoclastic vasculitis and necrolytic acral erythema in patients with hepatitis C infection: Do viral load and viral genotype play a role?

      2010, Journal of the American Academy of Dermatology
      Citation Excerpt :

      Moreover, Gadet al,35 in 2003, found that HCV genotype 1b in Japanese patients was more frequently associated with cryoglobulinemia than genotype 4 in Egyptian patients, however, ethnicity and genetic factors could have played a role in their findings. Other investigators found no difference in genotype prevalence between HCV-related cryoglobulinemia and chronic HCV without cryoglobulinemia.36,37 Only 3 studies, all from the United States, have investigated HCV genotype in patients presenting with NAE.

    • Dermatologic Disorders Associated With Chronic Hepatitis C: Effect of Interferon Therapy

      2007, Clinical Gastroenterology and Hepatology
      Citation Excerpt :

      Cryoprecipitates are rich in HCV RNA and anti-HCV.36,37 Between 25% and 50% of patients with chronic HCV have detectable cryoglobulinemia,49,50 with 10%–30% having symptoms.48–51 Conversely, up to 90% of MC patients are HCV-infected.48

    • Systemic vasculitis due to hepatitis C virus

      2006, Bulletin de l'Academie Nationale de Medecine
    • Chronic hepatitis C: Genotypes 4 to 9

      2005, Clinics in Liver Disease
    View all citing articles on Scopus
    View full text